MedTrace Logo

Early Discrimination of Periprosthetic Hip Infections Using Neural Networks (SEPTIC-ANNR)

NCT04119804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2024-10-28

No results posted yet for this study

Summary

The study is about the role of cellular neural networks-genetic algorithm in the diagnosis of periprosthetic hip infections. A retrospective case series of septic and aseptic loosening of primary hip arthroplasties is selected. The diagnosis of septic loosening is made according to well-established criteria (CDC 2014 and culture samples). The serial radiographs of the selected patients are processed using cellular neural networks-genetic algorithm. The purpose of this study is to evaluate whether neural networks (cellular neural networks-genetic algorithm), applied to conventional radiographies, are accurate, sensitive and specific for the early-discrimination of a periprosthetic hip infection, already diagnosed with well-recognized methods (CDC 2014).

Conditions

  • Hip Prosthesis Infection

Interventions

DIAGNOSTIC_TEST

cellular neural networks-genetic algorithm

Cellular neural networks-genetic algorithm applied to conventional radiographs of hip implants with a well-established diagnosis of loosening. The study is not intended to use a software without a CE mark as a medical device, or to use the software as a tool to diagnose or prevent human disease, according to Directive 93/42 / European Economic Community. The study will evaluate if the software, properly calibrated, is able to recognize with adequate accuracy infections already diagnosed with validated methods.

Sponsors & Collaborators

  • Università degli studi di Messina

    collaborator UNKNOWN

  • Istituto Ortopedico Rizzoli

    lead OTHER

Principal Investigators

  • Francesco Traina, PhD · IRCCS Istituto Ortopedico Rizzoli

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-03
Primary Completion
2024-01-20
Completion
2024-01-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04119804 on ClinicalTrials.gov